FDA Inspection 1226475 — Paul Poirier, M.D.
The FDA completed an inspection of Paul Poirier, M.D. on Dec 8, 2023 in Quebec. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Quebec (Canada)
Additional Details
Clinical Investigator (CI)